Overview

Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings

Status:
Completed
Trial end date:
2019-06-30
Target enrollment:
Participant gender:
Summary
In preparation for a large-scale randomized controlled trial (RCT) of Vivitrol® effectiveness in drug courts, investigators propose a feasibility study in the Wake County, North Carolina drug court, where an estimated 50% of clients are opioid dependent. Aim 1: Pilot RCT. Pilot-test the delivery of Vivitrol® treatment for 10-20 interested and eligible clients of the Wake County Drug Court.
Phase:
Phase 4
Details
Lead Sponsor:
Duke University
Collaborators:
Alkermes, Inc.
Drug Treatment Court (Wake County, NC)
FHR (Fellowship Health Resources, Inc.)
Laura and John Arnold Foundation
Treatments:
Naltrexone